Introduction: Staging of cervical cancer plays a major role in the treatment and prognosis of the patients. Preoperative Magnetic Resonance Imaging (MRI) is widely reviewed as a method to stage cervical cancer. Aim: To evaluate the role of MRI in the staging of cervical cancer in correlation with Histopathological Examination (HPE). Materials and Methods: A retrospective observational hospital- based study was done on 48 patients with Carcinoma Cervix attending the Velammal Medical College Hospital and Research Institute, Madurai, Tamilnadu. The patients, who had undergone MRI (on 1.5 Tesla Unit) of abdomen and pelvis from June 2018 to July 2019 were included in the study. Tumour location, size, vaginal, parametrial extension, pelvic sidewall involvement, pelvic and retroperitoneal lymphadenopathy, spread to adjacent pelvic organs and distant organs following retroperitoneal lymphadenopathy were reviewed from reports, and histopathology reports were analysed. International Federation of Gynaecology and Obstetrics (FIGO) staging was done for all the cases. HPE findings and MRI findings were assessed for correlation. IBM SPSS version 22.0 was used for statistical analysis. Descriptive analysis was carried out, and values were represented as mean with standard deviation for quantitative variables, frequency and proportion for categorical variables. Results: The mean age was 54.46±9.29 years. The majority 42 (87.5%) of the patients had Squamous cell carcinoma of the cervix on HPE. The majority 23 (47.91%) of the patients had stage IB carcinoma of the cervix. MRI revealed pelvic lymphadenopathy in 04 (8.33%) of cases, pelvic lymph nodal metastasis was seen in 02 (4.16%) of the HPE cases. Conclusion: MRI is useful in staging of Carcinoma cervix in stage IB or greater and for planning of treatment. Hence, MRI has the potential to be used as a one-stop-shop diagnostic tool for cervical cancer.
Read full abstract